Access the full text.
Sign up today, get DeepDyve free for 14 days.
Wei Chen, Yubin Wu, Y. Hu (2018)
Early (≤ 30 Days), Late (31–360 Days) and Very Late (> 360 Days) Stent Thrombosis in Patients with Insulin-Treated versus Non-Insulin-Treated Type 2 Diabetes Mellitus: A Meta-AnalysisDiabetes Therapy, 9
A. Jagroop, D. Mikhailidis (2015)
Platelets and diabetes: A complex associationPlatelets, 26
T. Takayama, T. Hiro, A. Hirayama (2011)
Stent thrombosis and drug-eluting stents.Journal of cardiology, 58 2
Seung-Hoon Pi, T. Rhee, J. Lee, D. Hwang, Jonghanne Park, T. Park, Jeong Yang, Y. Song, Jin‐Ho Choi, J. Hahn, Byung-jin Kim, B. Kim, H. Gwon, Seung‐Hyuk Choi (2018)
Outcomes in Patients with Diabetes Mellitus According to Insulin Treatment After Percutaneous Coronary Intervention in the Second-Generation Drug-Eluting Stent Era.The American journal of cardiology, 121 12
A. Liberati, D. Altman, J. Tetzlaff, C. Mulrow, P. Gøtzsche, J. Ioannidis, M. Clarke, P. Devereaux, J. Kleijnen, D. Moher (2009)
The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaborationThe BMJ, 339
E. Asher, Arsalan Abu-Much, I. Goldenberg, A. Segev, A. Sabbag, I. Mazin, Meital Shlezinger, S. Atar, D. Zahger, A. Polak, R. Beigel, S. Matetzky (2016)
Incidence and Clinical Features of Early Stent Thrombosis in the Era of New P2y12 Inhibitors (PLATIS-2)PLoS ONE, 11
Tadayuki Kadohira, Yoshio Kobayashi, Tatsuhiko Asano, M. Uehara, N. Funabashi, T. Nakayama, N. Kuroda, I. Komuro (2008)
Fatal very late stent thrombosis in a young diabetic patient with severely diffuse coronary atherosclerosis.International heart journal, 49 4
A. Banning, S. Westaby, M. Morice, A. Kappetein, F. Mohr, S. Berti, M. Glauber, M. Kellett, R. Kramer, Katrin Leadley, K. Dawkins, P. Serruys (2010)
Diabetic and nondiabetic patients with left main and/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents.Journal of the American College of Cardiology, 55 11
D. Kereiakes, D. Cutlip, R. Applegate, John Wang, M. Yaqub, P. Sood, Xiaolu Su, Guo-Zhu Su, Naim Farhat, A. Rizvi, C. Simonton, K. Sudhir, G. Stone (2010)
Outcomes in diabetic and nondiabetic patients treated with everolimus- or paclitaxel-eluting stents: results from the SPIRIT IV clinical trial (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System).Journal of the American College of Cardiology, 56 25
YJ Jiang, WX Han, C Gao, J Feng, ZF Chen, J Zhang, CM Luo, JY Pan (2017)
Comparison of clinical outcomes after drug-eluting stent implantation in diabetic versus nondiabetic patients in China: A retrospective studyMedicine (Baltimore)., 96
A. Syed, I. Ben‐dor, Yanlin Li, S. Collins, Manuel Gonzalez, M. Gaglia, Gabriel Maluenda, C. Delhaye, K. Wakabayashi, L. Bonello, A. Labriolle, L. Belle, R. Torguson, Zhenyi Xue, Kimberly Kaneshige, N. Bernardo, L. Satler, K. Kent, W. Suddath, A. Pichard, J. Lindsay, R. Waksman (2010)
Outcomes in diabetic versus nondiabetic patients who present with acute myocardial infarction and are treated with drug-eluting stents.The American journal of cardiology, 105 6
B. Brodie, Y. Pokharel, Nathan Fleishman, Adam Bensimhon, G. Kissling, C. Hansen, Sally Milks, M. Cooper, C. McAlhany, T. Stuckey (2011)
Very late stent thrombosis after primary percutaneous coronary intervention with bare-metal and drug-eluting stents for ST-segment elevation myocardial infarction: a 15-year single-center experience.JACC. Cardiovascular interventions, 4 1
A. Jain, C. Lotan, I. Meredith, F. Feres, R. Zambahari, N. Sinha, M. Rothman (2010)
Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: results from the E-Five RegistryHeart, 96
P. Bundhun, Akash Bhurtu, M. Soogund, Man-Yun Long (2016)
Comparing the Clinical Outcomes between Drug Eluting Stents and Bare Metal Stents in Patients with Insulin-Treated Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of 10 Randomized Controlled TrialsPLoS ONE, 11
A. Liberati, D. Altman, J. Tetzlaff, C. Mulrow, P. Gøtzsche, J. Ioannidis, M. Clarke, P. Devereaux, J. Kleijnen, D. Moher (2009)
The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and ElaborationPLoS Medicine, 6
Yong-Jin Jiang, W. Han, Chao Gao, Jun Feng, Zhengfei Chen, Jing Zhang, Chunmiao Luo, Jianyuan Pan (2017)
Comparison of clinical outcomes after drug-eluting stent implantation in diabetic versus nondiabetic patients in ChinaMedicine, 96
P. Bundhun, M. Soogund, Manish Pursun, Mengjun Chen (2016)
Stent thrombosis and adverse cardiovascular outcomes observed between six months and five years with sirolimus-eluting stents and other drug-eluting stents in patients with Type 2 diabetes mellitus complicated by coronary artery diseaseMedicine, 95
L. Jensen, M. Maeng, P. Thayssen, A. Kaltoft, H. Tilsted, J. Lassen, K. Hansen, M. Bøttcher, K. Rasmussen, M. Madsen, S. Johnsen, H. Sørensen, L. Thuesen (2010)
Long-term outcomes after percutaneous coronary intervention in patients with and without diabetes mellitus in Western Denmark.The American journal of cardiology, 105 11
PK Bundhun, MZ Soogund, M Pursun, MH Chen (2016)
Stent thrombosis and adverse cardiovascular outcomes observed between six months and five years with sirolimus-eluting stents and other drug-eluting stents in patients with type 2 diabetes mellitus complicated by coronary artery disease: a systematic review and meta-analysisMedicine (Baltimore)., 95
T. Stuckey, A. Kirtane, B. Brodie, B. Witzenbichler, Claire Litherland, G. Weisz, M. Rinaldi, F. Neumann, D. Metzger, T. Henry, T. Henry, D. Cox, Peter Duffy, E. Mazzaferri, P. Gurbel, R. Mehran, P. Généreux, P. Généreux, O. Ben-Yehuda, C. Simonton, G. Stone, Adapt-Des Investigators (2017)
Impact of Aspirin and Clopidogrel Hyporesponsiveness in Patients Treated With Drug-Eluting Stents: 2-Year Results of a Prospective, Multicenter Registry Study.JACC. Cardiovascular interventions, 10 16
S. Silber, P. Serruys, M. Leon, I. Meredith, S. Windecker, F. Neumann, J. Belardi, P. Widimsky, J. Massaro, V. Novack, A. Yeung, S. Saito, L. Mauri (2013)
Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program.JACC. Cardiovascular interventions, 6 4
J. Arthur, K. Jandeleit-Dahm, R. Andrews (2016)
Platelet Hyperreactivity in Diabetes: Focus on GPVI Signaling—Are Useful Drugs Already Available?Diabetes, 66
J. Higgins, S. Thompson, J. Deeks, D. Altman (2003)
Measuring inconsistency in meta-analysesBMJ : British Medical Journal, 327
AK Jain, C Lotan, IT Meredith, F Feres, R Zambahari, N Sinha (2010)
Rothman MT; E-Five Registry Investigators. Twelve-month outcomes in patients with diabetes implanted with a zotarolimus-eluting stent: results from the E-Five RegistryHeart, 96
Ramon Partida, R. Yeh (2016)
Contemporary Drug-Eluting Stent Platforms: Design, Safety, and Clinical Efficacy.Interventional cardiology clinics, 5 3
A. Franzone, T. Pilgrim, D. Heg, M. Roffi, D. Tüller, A. Vuilliomenet, O. Muller, S. Cook, D. Weilenmann, C. Kaiser, P. Jamshidi, L. Räber, S. Stortecky, P. Wenaweser, P. Jüni, S. Windecker (2015)
Clinical Outcomes According to Diabetic Status in Patients Treated With Biodegradable Polymer Sirolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents: Prespecified Subgroup Analysis of the BIOSCIENCE TrialCirculation: Cardiovascular Interventions, 8
L. Jensen, P. Thayssen, A. Junker, M. Maeng, H. Tilsted, A. Kaltoft, K. Hansen, E. Christiansen, S. Kristensen, J. Ravkilde, M. Madsen, H. Sørensen, L. Thuesen, J. Lassen (2012)
Comparison of outcomes in patients with versus without diabetes mellitus after revascularization with everolimus- and sirolimus-eluting stents (from the SORT OUT IV trial).The American journal of cardiology, 110 11
Background Nowadays, drug-eluting stents (DES) are most commonly used compared with bare metal stents (BMS) since the former are associated with significantly lower rates of revascularization following percutaneous coronary intervention (PCI). However, unpredictable in-stent thrombosis is a major concern with DES, especially in patients with diabetes mellitus. Objective In this analysis, we aimed to systematically compare early and late stent thrombosis in patients with versus without diabetes mellitus following PCI with DES. Methods Studies were included if they were randomized controlled trials or observational studies comparing patients with diabetes mellitus versus those without it following PCI with DES and they reported acute and sub-acute/early and late stent thrombosis among their clinical outcomes. Early stent thrombosis was defined as stent thrombosis that occurred before 30 days and late stent thrombosis was defined as stent thrombosis that occurred after 30 days following PCI. The statistical analysis was carried out by the new version of the RevMan software (version 5.3), and odds ratios (ORs) and 95% confidence intervals (CIs) were considered as the statistical parameters. Results A total number of 18,910 patients were included in this analysis comparing early and late stent thrombosis in patients with diabetes mellitus (5123 patients) and in patients without
American Journal of Cardiovascular Drugs – Springer Journals
Published: Aug 22, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.